上海市锦天城（深圳）律师事务所 关于深圳市英可瑞科技股份有限公司 2025 年第一次临时股东大会的 法律意见书 上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于深圳市英可瑞科技股份有限公司 2025 年第一次临时股东大会的 法律意见书 致：深圳市英可瑞科技股份有限公司 上海市锦天城（深圳）律师事务所（以下简称"本所"）接受深圳市英可瑞科 技股份有限公司（以下简称"公司"）委托，就公司召开 2025 年第一次临时股东 大会（以下简称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》 （以下简称《公司法》）《上市公司股东会规则》等法律、法规、规章和其他规范 性文件以及《深圳市英可瑞科技股份有限公司章程》（以下简称《公司章程》）的 有关规定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的相关事 项进行了必要的核查和验证，核查了本所认为出具该法律意见书所需的相关文件、 资料，并参加了公司本次股东大会的全 ...

证券代码：300713 证券简称：英可瑞 公告编号：2025-039 深圳市英可瑞科技股份有限公司 2025年第一次临时股东大会决议公告 （2）网络投票：通过深圳证券交易所交易系统进行网络投票的具体时间为 2025年9月12日上午9:15—9:25，9:30—11:30，下午13:00—15:00；通过深圳证 券交易所互联网投票的具体时间为：2025年9月12日上午9:15至下午15:00期间的 任意时间。 3.会议地点：深圳市南山区中山园路1001号国际E城E1栋11楼公司大会议室。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会无增加、变更、否决议案的情形。 2.本次股东大会未涉及变更前次股东大会决议情况。 一、会议召开和出席情况 1.股东大会届次：2025年第一次临时股东大会 2.会议召开的日期、时间： （1）现场会议召开：2025年9月12日下午14:30时开始 4.会议召开方式：本次股东大会采用现场表决与网络投票相结合的方式。 5.股东大会的召集人：本次股东大会的召集人为董事会。 6.会议主持人：公司董事长尹伟先生。 7 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 9月9日下午3点至4点，深圳市英可瑞科技股份有限公司在深圳市龙岗区英可瑞科技楼一楼会议室，接受 了天治基金、国联民生两家机构的特定对象调研。英可瑞董事兼总经理王孟腾先生、财务总监孙晶女 士、董事会秘书邓琥先生以及证券事务代表向慧女士参与接待。 HVDC模块方面，公司HVDC电源及系统主要用于数据中心机房，目前HVDC电源模块产品采用风冷散 热技术。 股权激励方面，公司重视长期激励机制，将根据发展战略、经营情况及资本市场环境等综合考虑，若有 计划将依规履行审议程序并及时披露。 接待过程中，公司与投资者充分交流，严格遵守信息披露规定，未出现未公开重大信息泄露情况，并按 深交所要求签署调研《承诺书》。本次活动不涉及未公开披露的重大信息。 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息， ...

2024年1至12月份，英可瑞的营业收入构成为：新能源汽车行业占比56.35%，其他电源行业占比 26.17%，电力行业占比17.48%。 截至发稿，英可瑞市值为29亿元。 每经头条（nbdtoutiao）——雷军挥泪"斩"王腾，小米爱将泄密"失街亭"，大厂正风肃纪"拼牙口" 每经AI快讯，英可瑞（SZ 300713，收盘价：18.13元）发布公告称，2025年9月9日15:00-16:00，英可瑞 接受天治基金调研，公司董事兼总经理王孟腾、财务总监孙晶，董事会秘书邓琥、证券事务代表向慧参 与接待，并回答了投资者提出的问题。 （记者 曾健辉） ...

投资者关系活动记录表 | 投资者关系活动 | 特定对象调研 ☐ 分析师会议 | | --- | --- | | 类别 | | | ☐ | 媒体采访 业绩说明会 ☐ | | ☐ | 新闻发布会 路演活动 ☐ | | ☐ | 现场参观 | | ☐ | 其他（请文字说明其他活动内容） | | 参与单位名称及 | 天治基金、国联民生 | | 人员姓名 | | | 时间 | 2025年09月09日 15:00-16:00 | | 地点 | 深圳市龙岗区英可瑞科技楼一楼会议室 | | 上市公司接待人 | 董事兼总经理 王孟腾先生；财务总监 孙晶女士 | | 员姓名 | 董事会秘书 邓琥先生；证券事务代表 向慧女士 | | | 董事会秘书邓琥先生主持了本次活动，邓琥先生首先简要介绍公司基本情 | | | 况。之后与会人员采用问答形式进行了沟通，具体内容如下： | | 投资者关系活动 | | | | Q1．公司在传统新能源车和电力行业的业务规划？订单情况？ | | 主要内容介绍 | | | | 【回复】2025年上半年度，公司电动汽车充电电源产品营业收入 | | | 103,039,732.65元，同比上期增长91.05% ...

Group 1 - The company, InnoCare Pharma (英可瑞), reported that as of August 29, 2025, the total number of shareholders is approximately 14,500 [1]

Core Viewpoint - The financial report of Yingkerui (300713) for the first half of 2025 shows significant revenue growth but continued net losses, indicating potential challenges in profitability despite increased sales [1]. Financial Performance Summary - Total revenue for the first half of 2025 reached 197 million yuan, a year-on-year increase of 66.77% compared to 118 million yuan in the same period of 2024 [1]. - The net profit attributable to shareholders was -25.81 million yuan, improving by 11.20% from -29.06 million yuan in the previous year [1]. - The gross margin increased to 21.52%, up by 4.96% from 20.50% in 2024, while the net margin improved to -14.30%, a 49.69% increase from -28.42% [1]. - The total of selling, administrative, and financial expenses was 39.49 million yuan, accounting for 20.01% of revenue, a decrease of 21.07% year-on-year [1]. - The company's cash flow from operating activities showed a significant decline of 259.53%, attributed to increased payments to employees [3][5]. Balance Sheet Changes - Inventory increased by 58.68%, indicating a buildup of stock likely due to new product development and existing orders [1][4]. - Accounts receivable rose by 10.85% to 201 million yuan, reflecting increased sales [1][4]. - Interest-bearing liabilities increased by 35.81% to 140 million yuan, indicating higher debt levels [1]. - Cash and cash equivalents decreased by 43.50% to 45.86 million yuan, highlighting liquidity concerns [1]. Cash Flow Analysis - The net cash flow from financing activities decreased by 81.95%, primarily due to reduced bank borrowings [5]. - The net increase in cash and cash equivalents dropped by 247.35%, driven by higher employee payments and decreased borrowings [5]. Operational Insights - The increase in sales expenses by 25.78% and administrative expenses by 37.44% suggests rising operational costs, potentially impacting future profitability [4]. - The company has experienced a historical average return on invested capital (ROIC) of 1.48%, with a notably poor ROIC of -13.36% in 2024, indicating challenges in generating returns on investments [5].

Financial Performance - The company reported a total revenue of 197 million yuan for the first half of 2025, representing a year-on-year increase of 66.77% [1] - The net profit attributable to shareholders was -25.81 million yuan, an improvement of 11.2% compared to the previous year [1] - The gross margin increased to 21.52%, up by 4.96% year-on-year, while the net margin improved to -14.3%, a 49.69% increase [1] - The total of selling, administrative, and financial expenses was 39.49 million yuan, accounting for 20.01% of revenue, a decrease of 21.07% year-on-year [1] Balance Sheet Highlights - Inventory saw a significant increase of 58.68% year-on-year, indicating a buildup in stock [1] - Cash and cash equivalents decreased by 43.50% to 45.86 million yuan [3] - Accounts receivable rose by 10.85% to 201 million yuan, attributed to increased sales [3] - Interest-bearing debt increased by 35.81% to 140 million yuan [1] Cash Flow Analysis - Operating cash flow per share was -0.08 yuan, a decline of 259.53% year-on-year, indicating cash outflows [1][3] - The net cash flow from operating activities decreased significantly due to higher payments to employees [3] - The net cash flow from investing activities improved by 43.48%, reflecting reduced cash outflows for fixed and intangible asset purchases [3] Operational Insights - The increase in revenue was driven by a higher order volume, with operating income rising by 66.77% [3] - The company faced challenges with cash flow management, as indicated by the negative operating cash flow and the low ratio of cash to current liabilities at 28.4% [5] - Historical data shows a median Return on Invested Capital (ROIC) of 1.48%, with a particularly poor performance in 2024 at -13.36% [4]

Core Viewpoint - In the semi-annual report for 2025, Yingkerui (300713.SZ) disclosed that institutional investors hold a total of 5.9886 million shares, representing 3.77% of the company's total equity, indicating a decrease in institutional ownership compared to the previous quarter [1] Institutional Ownership - As of August 25, 2025, three institutional investors have disclosed their holdings in Yingkerui A-shares, with a combined ownership of 5.9886 million shares [1] - The total institutional ownership percentage has decreased by 1.17 percentage points compared to the previous quarter [1] Foreign Investment - Two foreign funds, BARCLAYS BANK PLC and UBS AG, have increased their holdings in Yingkerui, contributing to a slight rise in foreign ownership [1] - Notably, J.P. Morgan Securities PLC and Goldman Sachs LLC have not disclosed their holdings in this period, indicating a potential shift in foreign investment dynamics [1]

Core Viewpoint - Inke Rui (300713) announced that it will hold its first extraordinary general meeting of shareholders in 2025 on September 12, 2025, to review multiple proposals including amendments to the company's articles of association and governance systems [1] Group 1 - The extraordinary general meeting is scheduled for September 12, 2025 [1] - The agenda includes the proposal to amend the company's articles of association [1] - Additional governance system proposals will also be reviewed during the meeting [1]